|Home||» Products||» Active Pharmaceutical Ingredients||» Active Pharmaceutical Ingredients By Alphabet E||» Eslicarbazepine|
- Place of Origin
- Other Names
- Pharmaceutical Industry
- FOB Port
- Payment Terms
- Letter of Credit (L/C), Telegraphic Transfer (T/T), Cash in Advance (CID)
- Supply Ability
- 1000 KG Per Week
- Delivery Time
- 7 Days
- Main Export Market(s)
- Australia, Central America, North America, South America, Eastern Europe, Western Europe, Middle East, Africa
Eslicarbazepine acetate abbreviated as ESL, is an anticonvulsant medication approved for use in Europe and the United States as monotherapy or adjunctive therapy (additional therapy) for partial-onset seizures epilepsy.
Similarly to oxcarbazepine, ESL behaves as a prodrug to (S)-(+)-licarbazepine.As such, their mechanisms of action are identical.